Literature DB >> 27465855

Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.

Pratistha Dwivedi1, Syed Imteyaz Alam2, Rajesh Singh Tomar3.   

Abstract

Functional genomics has made possible advanced structure-to-function investigation of pathogens and helped characterize virulence mechanisms. Proteomics has been become a tool for large-scale identification of proteins involved during invasion and infection by the pathogens. Bacterial surface and secreted proteins play key role in the interaction between the bacterial cell and the host environment. Thus exoproteome and surface proteome of a microorganism are hypothesized to contain components of effective vaccines. Surfome and exoproteome analysis strategy facilitates identification of novel vaccine antigen and overall helps in progress of discovery of vaccine. The study of the antibody response can advance how proteomics is used, because it investigates antibody-antigen interactions and also unravel the relationship of antibody responses to pathogen and host characteristics. System immunology integrating with proteome i.e. immunoproteomics is applicable to those infections that are having tendency of diverse antibody target recognition and thus accurately reflects progression of the infection.

Entities:  

Keywords:  Exoproteome; Immunoproteomics; Surface proteome; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27465855     DOI: 10.1007/s11274-016-2107-3

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  60 in total

1.  Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach.

Authors:  Chi-Won Choi; Yeol Gyun Lee; Sang-Oh Kwon; Hye-Yeon Kim; Je Chul Lee; Young-Ho Chung; Chi-Young Yun; Seung Il Kim
Journal:  Diagn Microbiol Infect Dis       Date:  2012-02-04       Impact factor: 2.803

2.  Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

Authors:  Joseph P Connolly; Diego Comerci; Timothy G Alefantis; Alexander Walz; Marian Quan; Ryan Chafin; Paul Grewal; Cesar V Mujer; Rodolfo A Ugalde; Vito G DelVecchio
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

3.  Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.

Authors:  Yanling Yang; Lin Wang; Jigang Yin; Xinglong Wang; Shipeng Cheng; Xulong Lang; Xiuran Wang; Hailong Qu; Chunhui Sun; Jinglong Wang; Rui Zhang
Journal:  Mol Immunol       Date:  2011-09-22       Impact factor: 4.407

4.  Comparative proteome analysis of secretory proteins from pathogenic and nonpathogenic Listeria species.

Authors:  Matthias Trost; Dirk Wehmhöner; Uwe Kärst; Guido Dieterich; Jürgen Wehland; Lothar Jänsch
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

5.  Immunoproteomics-Based Analysis of the Immunocompetent Serological Response to Lomentospora prolificans.

Authors:  Aize Pellon; Andoni Ramirez-Garcia; Idoia Buldain; Aitziber Antoran; Aitor Rementeria; Fernando L Hernando
Journal:  J Proteome Res       Date:  2016-01-21       Impact factor: 4.466

6.  Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics.

Authors:  Matthew S Walters; Harry L T Mobley
Journal:  J Microbiol Methods       Date:  2009-05-06       Impact factor: 2.363

7.  Growth phase-dependent composition of the Helicobacter pylori exoproteome.

Authors:  Christina A Snider; Bradley J Voss; W Hayes McDonald; Timothy L Cover
Journal:  J Proteomics       Date:  2015-09-09       Impact factor: 4.044

8.  Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.

Authors:  Ryszard A Zielke; Igor H Wierzbicki; Benjamin I Baarda; Philip R Gafken; Olusegun O Soge; King K Holmes; Ann E Jerse; Magnus Unemo; Aleksandra E Sikora
Journal:  Mol Cell Proteomics       Date:  2016-05-02       Impact factor: 5.911

9.  MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.

Authors:  James S Testa; Vivekananda Shetty; Julie Hafner; Zacharie Nickens; Shivali Kamal; Gomathinayagam Sinnathamby; Ramila Philip
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.

Authors:  Syed Imteyaz Alam; Sunita Bansod; Lokendra Singh
Journal:  BMC Microbiol       Date:  2008-11-11       Impact factor: 3.605

View more
  5 in total

1.  Immunoproteomics to identify Staphylococcus aureus antigens expressed in bovine milk during mastitis.

Authors:  N Misra; X Pu; D N Holt; M A McGuire; J K Tinker
Journal:  J Dairy Sci       Date:  2018-05-03       Impact factor: 4.034

2.  Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against Helicobacter pylori.

Authors:  Victor Hugo Urrutia-Baca; Ricardo Gomez-Flores; Myriam Angélica De La Garza-Ramos; Patricia Tamez-Guerra; Daniela Guadalupe Lucio-Sauceda; María Cristina Rodríguez-Padilla
Journal:  J Comput Biol       Date:  2019-05-23       Impact factor: 1.479

Review 3.  The Mycoplasma spp. 'Releasome': A New Concept for a Long-Known Phenomenon.

Authors:  Patrice Gaurivaud; Florence Tardy
Journal:  Front Microbiol       Date:  2022-04-15       Impact factor: 5.640

4.  Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics.

Authors:  Salvador Eugenio C Caoili
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 5.  Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.

Authors:  Nicola Luigi Bragazzi; Vincenza Gianfredi; Milena Villarini; Roberto Rosselli; Ahmed Nasr; Amr Hussein; Mariano Martini; Masoud Behzadifar
Journal:  Front Public Health       Date:  2018-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.